ストックスクリーナーアプリを入手
129.16
0.84%
-1.6905
前日終値:
$130.85
開ける：
$129.77
24時間の取引高:
97,860
Relative Volume:
0.13
時価総額：
$4.43B
収益：
$605.49M
当期純損益:
$190.29M
株価収益率:
26.59
EPS:
4.8571
ネットキャッシュフロー:
$133.59M
1週間 パフォーマンス:
-12.12%
1か月 パフォーマンス:
-2.66%
6か月 パフォーマンス:
+10.91%
1年 パフォーマンス:
+91.81%
1日の値動き範囲:
$129.07
$132.19
1週間の範囲:
$122.38
$147.50
52週間の値動き範囲:
$62.23
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
名前
Transmedics Group Inc
セクター
電話
(978) 552-0900
住所
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
129.11 | 4.49B | 605.49M | 190.29M | 133.59M | 4.8571 |
|
ABT
Abbott Laboratories
|
110.13 | 192.10B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
343.37 | 137.25B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
89.00 | 115.41B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
68.89 | 103.81B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
84.48 | 49.82B | 6.07B | 1.06B | 1.34B | 1.8063 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-10-23 | アップグレード | Needham | Hold → Buy |
| 2025-10-13 | 開始されました | Jefferies | Buy |
| 2025-09-16 | 開始されました | Evercore ISI | Outperform |
| 2025-09-04 | 開始されました | Stifel | Hold |
| 2024-12-17 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-11-22 | ダウングレード | Needham | Buy → Hold |
| 2024-10-29 | 繰り返されました | Needham | Buy |
| 2024-10-29 | 繰り返されました | Oppenheimer | Outperform |
| 2024-09-24 | 開始されました | Robert W. Baird | Outperform |
| 2024-08-21 | 開始されました | Needham | Buy |
| 2024-06-06 | 開始されました | Cantor Fitzgerald | Overweight |
| 2024-06-04 | 開始されました | Stephens | Overweight |
| 2024-03-28 | 開始されました | Piper Sandler | Overweight |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2022-08-02 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-10-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2020-04-07 | 開始されました | Oppenheimer | Outperform |
| 2019-05-28 | 開始されました | Canaccord Genuity | Buy |
| 2019-05-28 | 開始されました | Cowen | Outperform |
| 2019-05-28 | 開始されました | JP Morgan | Overweight |
| 2019-05-28 | 開始されました | Morgan Stanley | Equal-Weight |
すべてを表示
Transmedics Group Inc (TMDX) 最新ニュース
Blair William & Co. IL Lowers Stake in TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics group CFO Hernandez sells shares worth $1.12 million By Investing.com - Investing.com Nigeria
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Stockholders to Connect - ACCESS Newswire
TransMedics group CFO Hernandez sells shares worth $1.12 million - Investing.com
(TMDX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Fieldview Capital Management LLC Acquires New Position in TransMedics Group, Inc. $TMDX - MarketBeat
Got $5,000? TransMedics Could Be a High‑Tech Organ Transplant Moonshot - AOL.com
12 Best Under-the-Radar Stocks to Buy According to Hedge Funds - Insider Monkey
TransMedics: Trials Should Broaden OCS Adoption, Watch For Headwinds (Downgrade) (TMDX) - Seeking Alpha
TransMedics Group (TMDX) Analyst Ratings Update: Stifel Raises P - GuruFocus
TransMedics: Numb Reaction To Extraordinary Fundamentals (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group (NASDAQ:TMDX) Price Target Raised to $130.00 - MarketBeat
Stifel raises TransMedics stock price target to $130 on liver strength - Investing.com
Assessing TransMedics Group (TMDX) Valuation After Recent Short Term Share Price Weakness - Yahoo Finance
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? - The Motley Fool
TransMedics Stock Is Up 104% Over the Last Year: Is It Too Late to Buy for 2026? - The Motley Fool
4 Top Stocks Long-Term Investors Should Buy in March - The Globe and Mail
Lovell, TransMedics director, sells $178k in TMDX stock - Investing.com Nigeria
Weill David sells TransMedics (TMDX) shares worth $524,294 - Investing.com Nigeria
Weill David sells TransMedics (TMDX) shares worth $524,294 By Investing.com - Investing.com India
Insider Sell: Stephanie Lovell Sells Shares of TransMedics Group Inc (TMDX) - GuruFocus
Stephanie Lovell Sells 1,193 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
TransMedics Group (NASDAQ:TMDX) Director David Weill Sells 3,571 Shares - MarketBeat
TransMedics Group Signals Strong Growth in Earnings Call - TipRanks
TransMedics Group Inc. (NASDAQ:TMDX) Combines Strong Earnings Momentum with Bullish Technical Setup - ChartMill
A Look At TransMedics Group (TMDX) Valuation After Strong Results And Optimistic Revenue Guidance - simplywall.st
Anil Ranganath Sells 864 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
Insider Selling: TransMedics Group (NASDAQ:TMDX) CFO Sells 375 Shares of Stock - MarketBeat
Nicholas Corcoran Sells 2,966 Shares of TransMedics Group (NASDAQ:TMDX) Stock - MarketBeat
TransMedics Group (NASDAQ:TMDX) CFO Sells $1,065,211.56 in Stock - MarketBeat
The medtech firm’s latest quarter showed organ demand – and profits – continuing to rise. - Finimize
TransMedics Group, Inc. $TMDX Shares Acquired by DNB Asset Management AS - MarketBeat
Why TransMedics Group (TMDX) Is Up 9.2% After Strong 2025 Results And 2026 Outlook - Sahm
TransMedics Group, Inc. (TMDX) Stock Analysis: Strong Growth with a 54.24% Return on Equity - DirectorsTalk Interviews
TransMedics Group, Inc. $TMDX Shares Acquired by Citigroup Inc. - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating TransMedics Group, Inc. (TMDX) And Encourages Shareholders to Connect - ACCESS Newswire
TD Cowen Health Care Conference - marketscreener.com
TransMedics Stock Soars After Beating Revenue Expectations and Raising Guidance - timothysykes.com
Wall Street Zen Downgrades TransMedics Group (NASDAQ:TMDX) to Hold - MarketBeat
TransMedics Shares Surge Amid Strong Q4 Financial Performance - StocksToTrade
TransMedics’ Shares Surge on Strong Q4 Results and Price Target Raises - StocksToTrade
TransMedics Stock Surges as Analysts Raise Price Targets Amid Strong Earnings - timothysykes.com
TransMedics Stock Surges After Outstanding Q4 Earnings and Strategic Expansion Plans - StocksToTrade
TransMedics Group (NASDAQ:TMDX) Shares Up 5.9%What's Next? - MarketBeat
Vanguard Group Inc. Buys 9,650 Shares of TransMedics Group, Inc. $TMDX - MarketBeat
TransMedics provides information on impact of release of valuation allowance on deferred tax assets on previously reported quarterly results - marketscreener.com
TransMedics clarifies Q4 tax benefit impact on earnings - Investing.com
TransMedics Provides Additional Information on the Impact of the Release of the Valuation Allowance on Deferred Tax Assets on Previously Reported Fourth Quarter Financial Results - PR Newswire
Analysts’ Top Healthcare Picks: Vaxcyte (PCVX), TransMedics Group (TMDX) - The Globe and Mail
TransMedics Group, Inc. (TMDX): A bull case theory - MSN
Is It Too Late To Consider TransMedics Group (TMDX) After Its 79% One-Year Surge? - Yahoo Finance
Transmedics Group Inc (TMDX) 財務データ
収益
当期純利益
現金流量
EPS
1.61%
1.39%
大文字化:
|
ボリューム (24 時間):